E

Emergent Biosolutions
D

EBS

8.06000
USD
-0.09
(-1.10%)
مغلق
حجم التداول
28,074
الربح لكل سهم
2
العائد الربحي
-
P/E
-2
حجم السوق
436,724,539
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    CBOE
    CBOE
    -4.560
    (-2.29%)
    195.000 USD
    CME
    CME
    -0.130
    (-0.05%)
    236.840 USD
    G
    GNK
    -0.280
    (-2.01%)
    13.650 USD
    H
    HAL
    -0.375
    (-1.44%)
    25.755 USD
    ICE
    ICE
    -1.305
    (-0.87%)
    148.285 USD
    NDAQ
    NDAQ
    -0.050
    (-0.06%)
    77.370 USD
    N
    NG
    -0.01500
    (-0.45%)
    3.31000 USD
    O
    OFG
    -0.265
    (-0.64%)
    40.985 USD
    المزيد
الأخبار

العنوان: Emergent Biosolutions

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN(R) and other commercial products.